ProMIS Neurosciences Granted US Patent 12,071,472 For "Methods Of Reducing Toxicity Induced By Amyloid Beta Oligomers Using Antibodies Specific To A-Beta Oligomers" In Alzheimer's Treatment
ProMIS Neurosciences Granted US Patent 12,071,472 For "Methods Of Reducing Toxicity Induced By Amyloid Beta Oligomers Using Antibodies Specific To A-Beta Oligomers" In Alzheimer's Treatment
ProMIS Neurosciences被授予美國專利12,071,472，用於「使用特異於A-Beta寡聚體的抗體減少澱粉樣β寡聚體引起的毒性」在阿爾茨海默病治療中
ProMIS Neurosciences Granted US Patent 12,071,472 For "Methods Of Reducing Toxicity Induced By Amyloid Beta Oligomers Using Antibodies Specific To A-Beta Oligomers" In Alzheimer's Treatment
ProMIS Neurosciences被授予美國專利12,071,472，用於「使用特異於A-Beta寡聚體的抗體減少澱粉樣β寡聚體引起的毒性」在阿爾茨海默病治療中
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間